Vice President, Emerging Company DevelopmentDepartment: Emerging Company Development
Mike Carnes leads the Emerging Company Development team at NCBiotech. In this role, he identifies and evaluates promising early-stage life science companies for NCBC loans. Mike provides business and financing strategy support to portfolio companies to help them raise follow-on investment capital and grow their business in North Carolina.
Mike has over a decade of experience providing business mentorship and training to support emerging life science companies, focusing on raising grant and equity financing. This includes his role at the NC Small Business and Technology Development Center where he contributed to over $200M in capital raised by client companies. As Equity Funding Specialist, he maintained connectivity with the investment community and participated in regional initiatives to enhance availability and access to early-stage investment capital. He also supported several university Technology Transfer offices where he participated in intellectual property management strategy as well as assisting with new university-based startup companies.
Mike earned a Bachelor of Science in Microbiology in 2006, a Professional Science Master’s in Microbial Biotechnology in 2012, and a Master’s in Business Administration with an emphasis in technology commercialization and entrepreneurship in 2013 from North Carolina State University. Before that time, Mike used his scientific and analytic skills as a bench researcher at Syngenta Biotechnology, Inc. and NCSU’s Department of Plant Pathology.